Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Oct 1;105(10):e540.
doi: 10.3324/haematol.2020.262345.

Dramatic presentation of acquired thombotic thrombocytopenic purpura associated with COVID-19

Marco Capecchi  1 , Cristina Mocellin  2 , Chiara Abbruzzese  3 , Ilaria Mancini  4 , Daniele Prati  2 , Flora Peyvandi  5
Affiliations
Case Reports

Dramatic presentation of acquired thombotic thrombocytopenic purpura associated with COVID-19

Marco Capecchi et al. Haematologica. .
No abstract available

PubMed Disclaimer

References

    1. Zsuzsanna V, Andreas JF, Peter S, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417-1418. - PMC - PubMed
    1. Saha M, McDaniel JK, Zheng XL. Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapeutics. J Thromb Haemost. 2017;15(10):1889-1900. - PMC - PubMed
    1. Réti M, Farkas P, Csuka D, et al. Complement activation in thrombotic thrombocytopenic purpura. J Thromb Haemost. 2012; 10(5):791-798. - PubMed
    1. Cugno M, Meroni PL, Gualtierotti R, et al. Complement activation in patients with COVID-19: a novel therapeutic target. J Allergy Clin Immunol. 2020;146(1):215-217. - PMC - PubMed
    1. Bérangère SJ, Coppo P, Veyradier A. Thrombotic thrombocytopenic purpura. Blood. 2017;129(21):2836-2846. - PubMed

Publication types